EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 3.0

Advantages of Sirolimus in a Calcineurin-Inhibitor Minimization Protocol for the Immunosuppressive Management of Kidney Allograft Recipients

Elias A. Rahal, Marita Chakhtoura, Rana Abu Dargham, Raja B. Khauli, Walid Medawar, Alexander M. Abdelnoor

ISRN Immunology · 2011

DOI: 10.5402/2011/536484 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift ISRN Immunology, 2011. Verfasst von Elias A. Rahal und 5 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A myriad of immunosuppressive agents is currently available for the management of graft recipients; however, a consensus on the optimum immunopharmacological plan is nonextant. Twenty kidney recipients on quadruple (mycophenolate mofetil, prednisone, cyclosporine A or tacrolimus, and sirolimus) therapy and 85 on triple therapy where sirolimus was excluded were analyzed for graft rejection or loss within a posttransplant surveillance period of 3 years. Only 1 of 20 recipients (5%) on quadruple therapy experienced a rejection episode. On the other hand, 13 of 85 recipients (15.3%) on triple therapy had a rejection episode or lost the graft. Overall, 14 of 105 recipients (13.3%) experienced a rejection episode or kidney loss. Our observations indicate that an immunosuppressive regimen including sirolimus is advantageous for the management of kidney allograft recipients in the short term.

Zitieren

APA

Rahal, E. A., Chakhtoura, M., Dargham, R. A., Khauli, R. B., Medawar, W., & Abdelnoor, A. M. (2011). Advantages of Sirolimus in a Calcineurin-Inhibitor Minimization Protocol for the Immunosuppressive Management of Kidney Allograft Recipients. ISRN Immunology. https://doi.org/10.5402/2011/536484

Vancouver

Rahal EA, Chakhtoura M, Dargham RA, Khauli RB, Medawar W, Abdelnoor AM. Advantages of Sirolimus in a Calcineurin-Inhibitor Minimization Protocol for the Immunosuppressive Management of Kidney Allograft Recipients. ISRN Immunology. 2011. doi:10.5402/2011/536484

BibTeX
@article{Rahal2011,
  author = {Rahal, Elias A. and Chakhtoura, Marita and Dargham, Rana Abu and Khauli, Raja B. and Medawar, Walid and Abdelnoor, Alexander M.},
  title = {Advantages of Sirolimus in a Calcineurin-Inhibitor Minimization Protocol for the Immunosuppressive Management of Kidney Allograft Recipients},
  journal = {ISRN Immunology},
  year = {2011},
  doi = {10.5402/2011/536484}
}
Kostenlos starten →